World's Best Scientists 2026 revealed!
Frank Grünebach

Frank Grünebach

D-Index & Metrics

Immunology

D-Index
43
Citations
7398
World Ranking
4842
National Ranking
310

Frank Grünebach publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Frank Grünebach sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 94 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Frank Grünebach D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Frank Grünebach sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Frank Grünebach is affiliated with the University of Tübingen in Germany. Their research primarily falls within the field of Immunology and Microbiology, with five publications contributing to this area. Their work also intersects with subfields including Immunology and Molecular Biology.

Their research topics focus on several areas related to immune system function and pathology. These include:

  • Immune Cell Function and Interaction
  • Inflammasome and Immune Disorders
  • Immune Response and Inflammation
  • T-cell and B-cell Immunology
  • Immunodeficiency and Autoimmune Disorders

Grünebach's scholarly output includes recent papers demonstrating engagement with both clinical and molecular aspects of immunology. Notable publications are:

  • "Monocyte-derived dendritic cells display a highly activated phenotype and altered function in patients with familial Mediterranean fever," 2020, published in Clinical & Experimental Immunology
  • "Deletion of the HLA-B Gene in One of the Inherited Haplotypes in a Northern European Family," 2025, published in HLA

Frequent collaborators contributing to their research include:

  • Reinhild Klein
  • Tanja Funk
  • Alexander R. Fuchs
  • Vanessa Altdörfer
  • Stella E. Autenrieth

Their work appears in specialized venues relevant to immunology and histocompatibility, specifically Clinical & Experimental Immunology and HLA journals.

Best Publications

  • Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

    Susanne M. Schmidt;Kerstin Schag;Martin R. Müller;Markus M. Weck

  • Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells

    Wichard Vogel;Frank Grünebach;Conrad A Messam;Lothar Kanz

  • Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ

    Alessio Nencioni;Frank Grünebach;Anke Zobywlaski;Claudio Denzlinger

  • Proteasome inhibitors: antitumor effects and beyond.

    A Nencioni;F Grünebach;F Patrone;A Ballestrero

  • The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

    Peter Brossart;Anya Schneider;Patricia Dill;Theodora Schammann

  • Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses

    Julia Hilpert;Ludger Grosse-Hovest;Frank Grünebach;Corina Buechele

  • PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways

    Silke Appel;Valdete Mirakaj;Anita Bringmann;Markus M. Weck

  • Generation of Functional Human Dendritic Cells From Adherent Peripheral Blood Monocytes by CD40 Ligation in the Absence of Granulocyte-Macrophage Colony-Stimulating Factor

    Peter Brossart;Frank Grünebach;Gernot Stuhler;Volker L. Reichardt

  • Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro transcribed MUC1 RNA

    Daniela Dörfel;Silke Appel;Frank Grünebach;Markus M. Weck

  • Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.

    Martin R. Müller;Frank Grünebach;Alessio Nencioni;Peter Brossart

  • Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

    Silke Appel;Andreas M. Boehmler;Frank Grünebach;Martin R. Müller

  • Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity.

    Alessio Nencioni;Julia Beck;Daniela Werth;Frank Grünebach

  • Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation.

    Alessio Nencioni;Karin Schwarzenberg;Karin Schwarzenberg;Katharina M. Brauer;Katharina M. Brauer;Susanne M. Schmidt;Susanne M. Schmidt

  • Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells

    Peter Brossart;Anke Zobywalski;Frank Grünebach;Lars Behnke

  • Expression of MUC-1 Epitopes on Normal Bone Marrow: Implications for the Detection of Micrometastatic Tumor Cells

    Wolfram Brugger;Hans-Jörg Bühring;Frank Grünebach;Wichard Vogel

  • Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

    W. Brugger;J. Hirsch;F. Grünebach;R. Repp

  • Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes.

    F Grünebach;M R Müller;A Nencioni;P Brossart

  • CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.

    Tina Baessler;Jean Enno Charton;Benjamin Joachim Schmiedel;Frank Grünebach

  • Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA

    Caterina Milazzo;Volker L. Reichardt;Martin R. Müller;Frank Grünebach

  • TLR ligands differentially affect uptake and presentation of cellular antigens

    Markus Michael Weck;Frank Grünebach;Daniela Werth;Christian Sinzger

  • The use of dendritic cells in cancer immunotherapy

    Alessio Nencioni;Frank Grünebach;Susanne M. Schmidt;Martin R. Müller

Frequent Co-Authors

Peter Brossart
Peter Brossart University Hospital Bonn
Lothar Kanz
Lothar Kanz University of Tübingen
Alessio Nencioni
Alessio Nencioni University of Genoa
Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Hans-Jörg Bühring
Hans-Jörg Bühring University of Tübingen
Tim H. Brümmendorf
Tim H. Brümmendorf RWTH Aachen University
Alexander Steinle
Alexander Steinle Goethe University Frankfurt
Sebastian Wesselborg
Sebastian Wesselborg University of Tübingen
Kirsten Lauber
Kirsten Lauber Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing a related healthcare degree can open diverse career opportunities. Many professionals start with nursing programs and specialize later. Accelerated programs are an excellent option for students with a non-nursing background. For example, online absn programs for non nurses provide a fast-track path to enter the nursing field, laying a strong foundation for immunology-related roles.

Once in nursing, further specialization is possible through programs like the accelerated nurse practitioner program. These intensive courses prepare nurses for advanced practice roles, which can be highly relevant for immunology practitioners focusing on patient immune health.

Certification is another crucial step for career advancement. For example, those moving from general healthcare to more specialized fields may consider an acute care np certification, emphasizing skills in managing complex, critical conditions. This can complement immunology expertise in hospital or clinical settings.

Understanding earning potential is also essential when planning your studies. According to data on how much does a dnp make, salaries vary significantly by location and specialization, making it important to research financial prospects alongside educational choices.

Best Scientists Citing Frank Grünebach

Trending Scientists

Recently Published Articles